Researchers explore PKC role in lung disease

Researchers explore PKC role in lung disease
A JGP study examines the role of PKC in airway smooth muscle contraction and raises the possibility that this enzyme could be a therapeutic target for treating asthma, COPD, and other lung diseases. The diagram shown summarizes the pathways regulating airway smooth muscle contraction. Credit: Dixon, R.E., and L.F. Santana. 2013. J. Gen. Physiol.

New research examines the role of PKC in airway smooth muscle contraction and raises the possibility that this enzyme could be a therapeutic target for treating asthma, COPD, and other lung diseases.

In the lungs, pathological increases in the contraction of the (SMCs) lining airway walls—a process that decreases airflow—contribute to the chain of events leading to asthma and COPD, two common lung diseases. Jose Perez-Zoghbi and colleagues from Texas Tech University Health Sciences Center designed a series of experiments to investigate the role of the enzyme PKC in this process. The results, which appear in The Journal of General Physiology, provide new insight into the mechanisms involved in regulating luminal diameter of small airways and reveal PKC as a potential target for drug therapies.

The researchers used phase-contrast video microscopy, confocal microscopy, Western blot analysis, and pharmacological activators and inhibitors to investigate the role of PKC in airway SMC contraction in mouse lung slices. Their results suggest that activation of PKC in small airways promotes an influx of calcium into SMC and subsequent intracellular release of to generate low frequency SMC twitching. PKC activation also induces a strong calcium ion sensitization of contraction, eliciting a stronger contractile response to stimuli that increase free intracellular calcium. Consequently, activation downstream of various molecules, such as thrombin, that are present in the airways in conjunction with inflammatory , could sensitize the airway SMCs to contractile stimuli and contribute to the airway hyper responsiveness that is characteristic of asthma and COPD.

More information: Dixon, R.E., and L.F. Santana. 2013. J. Gen. Physiol. 141:161 Mukherjee, S., et al. 2013. J. Gen. Physiol. 141:165-178.

add to favorites email to friend print save as pdf

Related Stories

Calcium flow disruptions linked to heart failure

Jan 31, 2011

Excessive release of calcium inside cardiac muscle can cause sudden cardiac death in heart failure patients. New research has revealed how this could happen, opening up new possibilities for combating heart ...

Tweaking gene expression to repair lungs

Feb 25, 2013

A healthy lung has some capacity to regenerate itself like the liver. In COPD, these reparative mechanisms fail. HDAC therapies may be useful for COPD, as well as other airway diseases. The levels of HDAC2 ...

Recommended for you

West Africans get creative with Ebola awareness

1 hour ago

A young man on camera names the person who's challenged him to dump the contents of a bucket over his head. But in a twist on the ice bucket challenge, this man is soon drenched in frothy, soapy water—part ...

Canada pulling Ebola lab team from Sierra Leone

3 hours ago

Canada is evacuating a three-member mobile laboratory team from Sierra Leone after people in their hotel were diagnosed with Ebola. The World Health Organization earlier announced it is pulling a team out of the country.

User comments